These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3169073)

  • 21. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of fruits and vegetables on urinary stone risk factors.
    Meschi T; Maggiore U; Fiaccadori E; Schianchi T; Bosi S; Adorni G; Ridolo E; Guerra A; Allegri F; Novarini A; Borghi L
    Kidney Int; 2004 Dec; 66(6):2402-10. PubMed ID: 15569332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of pH on the risk of calcium oxalate crystallization in urine.
    Berg C; Tiselius HG
    Eur Urol; 1986; 12(1):59-61. PubMed ID: 3948899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurements of urinary state of saturation with respect to calcium oxalate and brushite (CaHPO4.2H2O) in renal stone formers.
    Sriboonlue P; Prasongwattana V; Tungsanga K; Sitprija V
    J Med Assoc Thai; 1990 Dec; 73(12):684-9. PubMed ID: 2086716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans.
    Hess B; Jost C; Zipperle L; Takkinen R; Jaeger P
    Nephrol Dial Transplant; 1998 Sep; 13(9):2241-7. PubMed ID: 9761503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary calcium oxalate saturation in 'stone formers' and normal subjects: an application of the EQUIL2 program.
    Robert M; Boularan AM; Colette C; Averous M; Monnier L
    Br J Urol; 1994 Apr; 73(4):358-61. PubMed ID: 8199821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis.
    Fetner CD; Barilla DE; Townsend J; Pak CY
    J Urol; 1978 Oct; 120(4):399-401. PubMed ID: 702659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis.
    Caudarella R; Rizzoli E; Buffa A; Bottura A; Stefoni S
    J Urol; 1998 Mar; 159(3):658-63. PubMed ID: 9474120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydration feature of urinary compounds. Evidence for molecular abnormality in calcium oxalate urolithiasis.
    Azoury R; Ramon J; Abrashkin S; Shalev J; Goldwasser B
    Urol Res; 1990; 18(1):7-11. PubMed ID: 2316076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in 24-hour urine composition between apatite and brushite stone formers.
    Moreira DM; Friedlander JI; Hartman C; Elsamra SE; Smith AD; Okeke Z
    Urology; 2013 Oct; 82(4):768-72. PubMed ID: 23791217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of calcium phosphate crystalluria: influence of pH and osmolality and invariable presence of oxalate.
    Hallson PC; Rose GA
    Br J Urol; 1989 Nov; 64(5):458-62. PubMed ID: 2611613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of high-calcium diet on urinary oxalate excretion in urinary stone formers.
    Nakada T; Sasagawa I; Furuta H; Katayama T; Shimazaki J
    Eur Urol; 1988; 15(3-4):264-70. PubMed ID: 3215261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of drinking bicarbonate-rich mineral water in calcium oxalate stone formers: an open label prospective randomized controlled study in an Asian cohort.
    Lu Y; Sundaram P; Li H; Chong TW
    Int Urol Nephrol; 2022 Sep; 54(9):2133-2140. PubMed ID: 35781772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of calcium oxalate crystalluria by infrared analysis].
    Tozuka K; Moriguchi H; Hara Y; Goto K; Tokue A
    Nihon Hinyokika Gakkai Zasshi; 1988 Oct; 79(10):1669-72. PubMed ID: 3251102
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of various calcium intakes on calcium-oxalate crystalluria in rats on sodium-oxalate diet.
    da Silva SL; Hennequin C; Droz D; Bader C; Daudon M; Drüeke T; Lacour B
    Nephrol Dial Transplant; 1994; 9(8):1090-6. PubMed ID: 7800206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystalluria in idiopathic recurrent calcium urolithiasis. Dependence on stone composition.
    Herrmann U; Schwille PO
    Urol Res; 1992; 20(2):157-64. PubMed ID: 1553791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.